A Nicolucci

Summary

Affiliation: Istituto di Ricerche Farmacologiche Mario Negri
Country: Italy

Publications

  1. ncbi Stratifying patients at risk of diabetic complications: an integrated look at clinical, socioeconomic, and care-related factors. SID-AMD Italian Study Group for the Implementation of the St. Vincent Declaration
    A Nicolucci
    Department of Clinical Pharmacology and Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, S Maria Imbaro, Italy
    Diabetes Care 21:1439-44. 1998
  2. ncbi Relationship between patient practice-oriented knowledge and metabolic control in intensively treated Type 1 diabetic patients: results of the validation of the Knowledge and Practices Diabetes Questionnaire
    A Nicolucci
    Department of Clinical Pharmacology and Epidemiology, Istituto Mario Negri, Consorzio Mario Negri Sud, S Maria Imbaro, Italy
    Diabetes Nutr Metab 13:276-83. 2000
  3. ncbi Why do we need outcomes research in end stage renal disease?
    A Nicolucci
    Dept of Clinical Pharmacology and Epidemiology, Mario Negri Sud Institute, S Maria Imbaro, Italy
    J Nephrol 13:401-4. 2000
  4. ncbi A comprehensive assessment of the avoidability of long-term complications of diabetes. A case-control study. SID-AMD Italian Study Group for the Implementation of the St. Vincent Declaration
    A Nicolucci
    Department of Clinical Pharmacology and Epidemiology, University of Chieti, Italy
    Diabetes Care 19:927-33. 1996
  5. ncbi The relationship between physicians' self-reported target fasting blood glucose levels and metabolic control in type 2 diabetes. The QuED Study Group--quality of care and outcomes in type 2 diabetes
    M Belfiglio
    Department of Clinical Pharmacology and Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, S. Maria Imbaro, Italy
    Diabetes Care 24:423-9. 2001
  6. ncbi The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies
    M Franciosi
    Department of Clinical Pharmacology and Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, S. Maria Imbaro, Italy
    Diabetes Care 24:1870-7. 2001
  7. ncbi Obesity and changes in urine albumin/creatinine ratio in patients with type 2 diabetes: the DEMAND study
    M C E Rossi
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S Maria Imbaro, CH, Italy
    Nutr Metab Cardiovasc Dis 20:110-6. 2010
  8. ncbi Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes
    A Nicolucci
    Dipartimento di Farmacologia Clinica e Epidemiologia, Consorzio Mario Negri Sud, S Maria Imbaro, Italy
    Nutr Metab Cardiovasc Dis 19:45-53. 2009
  9. ncbi The effectiveness, safety and epidemiology of the use of acarbose in the treatment of patients with type II diabetes mellitus. A model of medicine-based evidence
    N Scorpiglione
    Istituto di Ricerche Farmmacologiche Mario Negri, Department of Clinical Pharmacology and Epidemiology, Laboratory of Clinical Epidemiology of Diabetes and Cancer, S Mario Imbaro Chieti, Italy
    Eur J Clin Pharmacol 55:239-49. 1999
  10. ncbi ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trial
    M Franciosi
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S Maria Imbaro, Italy
    Diabet Med 28:789-96. 2011

Collaborators

Detail Information

Publications20

  1. ncbi Stratifying patients at risk of diabetic complications: an integrated look at clinical, socioeconomic, and care-related factors. SID-AMD Italian Study Group for the Implementation of the St. Vincent Declaration
    A Nicolucci
    Department of Clinical Pharmacology and Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, S Maria Imbaro, Italy
    Diabetes Care 21:1439-44. 1998
    ..The aim of this study was to identify subgroups of patients for whom the interactions among clinical, socioeconomic, and care-related factors determine a substantial increase in the risk of developing long-term diabetic complications...
  2. ncbi Relationship between patient practice-oriented knowledge and metabolic control in intensively treated Type 1 diabetic patients: results of the validation of the Knowledge and Practices Diabetes Questionnaire
    A Nicolucci
    Department of Clinical Pharmacology and Epidemiology, Istituto Mario Negri, Consorzio Mario Negri Sud, S Maria Imbaro, Italy
    Diabetes Nutr Metab 13:276-83. 2000
    ..To validate a newly developed questionnaire for the measurement of patients' knowledge and practices, with particular attention to its ability in predicting HbA1c levels...
  3. ncbi Why do we need outcomes research in end stage renal disease?
    A Nicolucci
    Dept of Clinical Pharmacology and Epidemiology, Mario Negri Sud Institute, S Maria Imbaro, Italy
    J Nephrol 13:401-4. 2000
    ..Outcomes research thus represents a unique opportunity to increase our knowledge on pre-ESRD care and to identify those strategies more likely to reduce the unwanted outcomes related to the initiation of dialytic treatment...
  4. ncbi A comprehensive assessment of the avoidability of long-term complications of diabetes. A case-control study. SID-AMD Italian Study Group for the Implementation of the St. Vincent Declaration
    A Nicolucci
    Department of Clinical Pharmacology and Epidemiology, University of Chieti, Italy
    Diabetes Care 19:927-33. 1996
    ....
  5. ncbi The relationship between physicians' self-reported target fasting blood glucose levels and metabolic control in type 2 diabetes. The QuED Study Group--quality of care and outcomes in type 2 diabetes
    M Belfiglio
    Department of Clinical Pharmacology and Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, S. Maria Imbaro, Italy
    Diabetes Care 24:423-9. 2001
    ..To improve patient outcomes, physicians-centered educational activities aimed at increasing the awareness of the potential benefits of a tight metabolic control in patients with type 2 diabetes are urgently needed...
  6. ncbi The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies
    M Franciosi
    Department of Clinical Pharmacology and Epidemiology, Istituto di Ricerche Farmacologiche Mario Negri, Consorzio Mario Negri Sud, S. Maria Imbaro, Italy
    Diabetes Care 24:1870-7. 2001
    ..In patients not treated with insulin, self-monitoring is associated with higher HbA(1c) levels and psychological burden. Our data do not support the extension of SMBG to this group...
  7. ncbi Obesity and changes in urine albumin/creatinine ratio in patients with type 2 diabetes: the DEMAND study
    M C E Rossi
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S Maria Imbaro, CH, Italy
    Nutr Metab Cardiovasc Dis 20:110-6. 2010
    ..It remains unclear whether this also applies to diabetic patients. We investigated whether obesity predicted changes in albumin excretion rate in individuals with type 2 diabetes...
  8. ncbi Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes
    A Nicolucci
    Dipartimento di Farmacologia Clinica e Epidemiologia, Consorzio Mario Negri Sud, S Maria Imbaro, Italy
    Nutr Metab Cardiovasc Dis 19:45-53. 2009
    ..In particular, we evaluated a large array of socio-economic, clinical, and management-related factors, to investigate the extent to which they correlate with physical and psychological well-being, and with treatment satisfaction...
  9. ncbi The effectiveness, safety and epidemiology of the use of acarbose in the treatment of patients with type II diabetes mellitus. A model of medicine-based evidence
    N Scorpiglione
    Istituto di Ricerche Farmmacologiche Mario Negri, Department of Clinical Pharmacology and Epidemiology, Laboratory of Clinical Epidemiology of Diabetes and Cancer, S Mario Imbaro Chieti, Italy
    Eur J Clin Pharmacol 55:239-49. 1999
    ..To assess the efficacy, safety and extent of perceived indications of acarbose, a new antidiabetic agent, under routine clinical practice conditions in an unselected Northern Italian population of type II diabetic patients...
  10. ncbi ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trial
    M Franciosi
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S Maria Imbaro, Italy
    Diabet Med 28:789-96. 2011
    ..To estimate the efficacy of a self-monitoring-based disease management strategy in patients with Type 2 diabetes treated with oral agent monotherapy...
  11. ncbi Impact of a chronic care model based on patient empowerment on the management of Type 2 diabetes: effects of the SINERGIA programme
    N Musacchio
    UOS Integrazione Cure Primarie e Specialistiche, Azienda Ospedaliera ICP, Milan Dipartimento di Farmacologia Clinica ed Epidemiologia, Consorzio Mario Negri Sud, Via Nazionale 66030, Santa Maria Imbaro CH, Italy
    Diabet Med 28:724-30. 2011
    ..e. a steady level of HbA(1c) without need for therapy changes) are included in the SINERGIA programme: diabetologists, nurses and dietitians empower patients and telemedicine resources are utilized efficiently...
  12. ncbi Correlates of quality of life in adults with type 1 diabetes treated with continuous subcutaneous insulin injection
    M Franciosi
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S Maria Imbaro Ch, Italy
    Nutr Metab Cardiovasc Dis 20:7-14. 2010
    ..A sample of consecutive patients completed the Diabetes Specific Quality of Life Scale (DSQOLS), investigating the daily burden and restrictions related to diabetes. Lower DSQOLS scores indicate worse QoL perception...
  13. ncbi The burden of hospitalization related to diabetes mellitus: a population-based study
    G De Berardis
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, Via Nazionale 8 A, S Maria Imbaro, Italy
    Nutr Metab Cardiovasc Dis 22:605-12. 2012
    ..To estimate the impact of diabetes and its complications, overall and in different age classes, on the likelihood of hospital admission for specific causes...
  14. ncbi Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes (LIRICO) randomized trial
    A Maione
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S Maria Imbaro, Chieti Italy
    J Nephrol 20:646-55. 2007
    ..Patients will be randomly allocated to ACEIs, ARBs or their combination. The study has been approved and funded by the Agenzia Italiana del Farmaco (A.I.F.A.) within the 2005 funding plan for independent research on drugs...
  15. ncbi Relationship of exercise volume to improvements of quality of life with supervised exercise training in patients with type 2 diabetes in a randomised controlled trial: the Italian Diabetes and Exercise Study (IDES)
    A Nicolucci
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S Maria Imbaro, Chieti, Italy
    Diabetologia 55:579-88. 2012
    ..Here, we report data on the relationship between changes in QoL and volume of physical activity/exercise in these individuals...
  16. ncbi Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ)
    A Nicolucci
    Dipartimento di Farmacologia Clinica e Epidemiologia, Consorzio Mario Negri Sud, S Maria Imbaro, CH, Italy
    Diabetes Nutr Metab 17:235-43. 2004
    ..To validate the Italian version of the World Health Organization (WHO)-Well-Being Questionnaire (WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (DTSQ) in Type 1 and Type 2 diabetic patients...
  17. ncbi Four-year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics: the AMD-Annals initiative
    A Nicolucci
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S Maria Imbaro, Italy
    Diabet Med 27:1041-8. 2010
    ..We evaluated the impact of a continuous quality improvement effort implemented by a network of Italian diabetes clinics operating in the national healthcare system...
  18. ncbi Persistent platelet activation in patients with type 2 diabetes treated with low doses of aspirin
    V Evangelista
    Department of Translational Pharmacology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Chieti, Italy
    J Thromb Haemost 5:2197-203. 2007
    ..The percentage of diabetic patients who do not benefit from the protective effect of aspirin is larger than in other populations at cardiovascular risk...
  19. ncbi Self-monitoring of blood glucose in non-insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control
    M Franciosi
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S. Maria Imbaro CH, Italy
    Diabet Med 22:900-6. 2005
    ..We could not identify any specific subgroups of patients for whom SMBG practice was associated with lower HbA1c levels during the study...
  20. ncbi Type and trends in outcomes research in breast cancer between 2000 and 2007
    M Valentini
    Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S Maria Imbaro, Italy
    Ann Oncol 22:2160-5. 2011
    ..We focused our research on OR in breast cancer, providing an overview of the trend of publications...